Form 4: Avanos Medical CEO Receives Stock Grant
Insider Transaction (Form 4)
David Pacitti, Chief Executive Officer of Avanos Medical, Inc., reported multiple transactions in common stock on July 27, 2026.
Summary
- Disposition to the issuer: disposed of 322,194 Common Stock at $25.00 ($8,054,850) on July 27, 2026 (Direct).
- Grant/award: acquired 444,730 Common Stock on July 27, 2026; holds 444,730 after (Direct).
- Disposition to the issuer: disposed of 444,730 Common Stock at $25.00 ($11,118,250) on July 27, 2026 (Direct).
- Disposition to the issuer: disposed of 239,354 Employee Stock Option (right to buy) on July 27, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
David Pacitti — Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-27 | Disposition to the issuer | Common Stock | 322,194 | $25 | $8.1M | 0 |
| 2026-07-27 | Grant/award | Common Stock | 444,730 | — | — | 444,730 |
| 2026-07-27 | Disposition to the issuer | Common Stock | 444,730 | $25 | $11.1M | 0 |
| 2026-07-27 | Disposition to the issuer | Employee Stock Option (right to buy) | 239,354 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-27 | Disposition to the issuer (322,194 shares) |
| 2026-07-27 | Grant/award (444,730 shares) |
| 2026-07-27 | Disposition to the issuer (444,730 shares) |
| 2026-07-27 | Disposition to the issuer (239,354 shares) |
Keywords
insider transaction, Form 4, AVNS, AVANOS MEDICAL, INC., neutral, David Pacitti
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.